In keeping with the newly defined mutational landscape of tumors, prostate cancer (CaP) also has extensive genetic alterations that range from single missense mutations, copy number variation, splicing variants, genetic rearrangements and short DNA alterations in a large number of genes [1], [2], [6], [7], including the androgen receptor (AR) gene. The gene discussed is AR; the disease is Familial prostate cancer.